Human mesenchymal stem cells enhance the systemic effects of radiotherapy

• Published in: Oncotarget 2015-10, Vol.6 (31), p.31164-31180
• Main Authors: de Araújo Farias, Virgínea, O'Valle, Francisco, Lerma, Borja Alonso, Ruiz de Almodóvar, Carmen, López-Peñalver, Jesús J, Nieto, Ana, Santos, Ana, Fernández, Beatriz Irene, Guerra-Librero, Ana, Ruiz-Ruiz, María Carmen, Guirado, Damián, Schmidt, Thomas, Oliver, Francisco Javier, Ruiz de Almodóvar, José Mariano
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis - radiation effects; Blotting, Western; Bystander Effect; Cell Proliferation - radiation effects; Cesium Radioisotopes; Gamma Rays; Humans; Immunoenzyme Techniques; Melanoma - genetics; Melanoma - pathology; Melanoma - therapy; Mesenchymal Stem Cell Transplantation; Mesenchymal Stromal Cells - cytology; Mice; Mice, Inbred NOD; Mice, SCID; Real-Time Polymerase Chain Reaction; Research Paper; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - genetics; Tumor Cells, Cultured; Xenograft Model Antitumor Assays
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.5216

The outcome of radiotherapy treatment might be further improved by a better understanding of individual variations in tumor radiosensitivity and normal tissue reactions, including the bystander effect. For many tumors, however, a definitive cure cannot be achieved, despite the availablity of more and more effective cancer treatments. Therefore, any improvement in the efficacy of radiotherapy will undoubtedly benefit a significant number of patients. Many experimental studies measure a bystander component of tumor cell death after radiotherapy, which highlights the importance of confirming these observations in a preclinical situation. Mesenchymal stem cells (MSCs) have been investigated for use in the treatment of cancers as they are able to both preferentially home onto tumors and become incorporated into their stroma. This process increases after radiation therapy. In our study we show that in vitro MSCs, when activated with a low dose of radiation, are a source of anti-tumor cytokines that decrease the proliferative activity of tumor cells, producing a potent cytotoxic synergistic effect on tumor cells. In vivo administration of unirradiated mesenchymal cells together with radiation leads to an increased efficacy of radiotherapy, thus leading to an enhancement of short and long range bystander effects on primary-irradiated tumors and distant-non-irradiated tumors. Our experiments indicate an increased cell loss rate and the decrease in the tumor cell proliferation activity as the major mechanisms underlying the delayed tumor growth and are a strong indicator of the synergistic effect between RT and MSC when they are applied together for tumor treatment in this model.